Stopped
Botensilimab (AGEN1181) · Advanced Melanoma
Trial terminated
Also in this update: Primary completion date changed from estimate of Feb 2028 to Apr 27, 2026
Agenus Inc.Phase 2 NCT05529316 Registry history of NCT05529316 on ClinicalTrials.gov (opens the registry)